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Early cellular and molecular events in inflamed skin include the active participa- 
tion of epidermal keratinocytes (KCs) and dermal mast cells which can produce 
diffusible mediators such as tumor necrosis factor-alpha (TNF-a), histamine, and 
urocanic acid (UCA). Rapid induction of adhesion molecules such as intercellular 
adhesion molecule-1 (ICAM-1) by KCs is  observed following a highly diverse array 
of stimuli which can provoke both irritant, inflammatory, as well as allergic and 
immune reactions. To determine if the aforementioned mediators could interact in 
either an additive or synergistic fashion with each other, cultured KCs were 
exposed to these mediators alone and in combination, and the degree of ICAM-1 
mRNA and protein quantitated. Whereas histamine or cis-UCA alone only weakly 
induced KC ICAM-1, when they were combined with TNF-a, significant augmen- 
tation was observed by Northern blot hybridization studies, immunostaining, and 
FACS analysis. Other histamine derivatives such as L-histidine, 1 methylhistidine, 
3-methylhistidine, or all-trans-UCA had no effect. Histamine pretreatment did not 
affect cell surface high affinity TNF-a receptors, as determined by ligand binding 
and immunodetection, and did not induce KC TNF-a production. The KC hista- 
mine receptor was also characterized and found not to be influenced by TNF-a, 
cis-UCA, all-trans-UCA, or diphenyhydramine (an H, antagonist), but it was 
inhibited by cimetidine (an H, antagonist). These results demonstrate that 1) KCs 
can be induced to express ICAM-1 by exposure to histamine and cis-UCA, 2) 
histamine and cis-UCA can also augment TNF-a inducible ICAM-1 mRNA and 
cell surface protein expression, 3) this augmentation does not directly involve 
changes in KC TNF-a receptor number, affinity, or TNF-a production and, 4) KCs 
possess a type 2 histamine receptor which i s  not the photoreceptor for UCA. These 
findings highlight the potential for cross-talk between molecules produced by 
resident cutaneous cell types above (i.e., KCs) and below (i.e., mast cells) the 
epidermal basement membrane zone. These cel Is and their mediators can coop- 
erate to respond to either exogenous or endogenous stimuli leading to rapid and 
strong KC ICAM-1 expression. Such induction of this important adhesion mole- 
cule by KCs ensures the retention of T lymphocytes necessary to participate in the 
maintenance of cutaneous immunohomeostasis. o 1993 Wiiey-Liss, Inc. 
In 1927 Sir Thomas Lewis proposed that the “triple 
response” of the skin following a wide variety of injuri- 
ous stimuli was mediated by the appearance of a solu- 
ble product in the immediate neighborhood of affected 
epidermal cells that he termed the “H-substance” 
(Lewis, 1927). Ten years earlier, it had been demon- 
strated that histamine injection into human epidermis 
produced capillary dilatation and whealing. Eventu- 
ally it was recognized that histamine was a potent local 
vasodilator, and that the H-substance and the mast cell 
derived histamine were identical (reviewed in Dale, 
1929). In 1991, Barker et al. postulated that kerati- 
nocytes (KCs) could initiate cutaneous inflammation 
following a wide variety of injurious stimuli by their 
production of the cytokine, tumor necrosis factor-alpha 
0 1993 WILEY-LISS, INC. 
(TNF-a). Thus, both mast cells and KCs may function 
as instigators of cutaneous inflammation via their pro- 
duction of diffusible molecular mediators. While there 
is a growing interest in the role of histamine in immu- 
Received November 23,1992; accepted March 22, 1993. 
*To whom reprint requestskorrespondence should be addressed. 
Presented in part at the European Congress on Wound Healing 
and Skin Physiology, Bochum, Germany, November 5-7, 1992. 
An abstract (in an upcoming issue of Journal of Investigative 
Dermatology) describing this work has been accepted for presen- 
tation at the upcoming Annual Meeting of the Society of Investi- 
gative Dermatology, Washington, D.C., April 28,1993. 
349 HISTAMINE, UROCANIC ACID, TNF-a INDUCE ICAM-1 EXPRESSION 
nological reactions, which complement its previous role 
in inflammation, there are relatively few reports that 
have explored the potential positivehegative interac- 
tion between histamine and immunomodulatory cyto- 
kines such as TNF-a (reviewed in Falus and Meretey, 
1992). Also, another histamine related compound 
known as urocanic acid (UCA) has gained increasing 
attention for its immunomodulatory role in skin dis- 
eases (Noonan and DeFabo, 1992). 
In this report, we asked whether there are any syner- 
gistic effects between histamine, UCA, and TNF-a with 
respect to the induction of KC intercellular adhesion 
molecule-1 (ICAM-1; CD-54) expression. KC ICAM-1 
expression was chosen for study because it is rapidly 
induced (within 24-48 hr) in a variety of irritant and 
allergic contact dermatitis reactions (reviewed in  Nick- 
cdoff, 1992). Moreover, following the epicutaneous ap- 
plication of the poison ivy antigen-urushiol, KC 
ICAM-1 expression actually precedes any significant 
trafficking of bloodstream derived mononuclear leuko- 
cytes, suggesting that endogenously derived mediators 
produced by locally resident cutaneous cells are capable 
of triggering this epidermal immunomodulatory event 
(Griffiths and Nickoloff, 1989). In this report, we dem- 
onstrate that histamine or cis-UCA can directly induce 
EL relatively low level of KC ICAM-1 expression, but 
when histamine or cis-UCA is combined with TNF-a, 
hoth further augment the induction of ICAM-1. 
MATERIALS AND METHODS 
KC culture 
Using a Castroveijo keratome, primary KC cultures 
were obtained from normal-appearing skin of healthy 
adult volunteers without any skin disease and not on 
any medication. All volunteers gave written informed 
consent, with approval by the Human Subjects Com- 
mittee of the University of Michigan. A single cell sus- 
pension was prepared as previously described (Griffiths 
et al., 1989). Freshly isolated epidermal cells were 
seeded into 35 mm polystyrene tissue culture dishes 
(Corning Glass Works, Corning, NY) and grown in the 
presence of a low calcium (0.15 mM) serum free me- 
dium containing epidermal growth factor (EGF, 10 ngi 
nnl), insulin (5 pg/ml), hydrocortisone (0.5 pg/ml), and 
bovine pituitary extract 0.4% vlv, designated KGM 
(Clonetics Corporation, San Diego, CAI. Culture dishes 
were incubated in a humidified atmosphere containing 
5% CO, at 37°C and the KCs were routinely passaged 
by using 0.03% trypsin/O.Ol% ethylenediaminetet- 
raacetic acid (EDTA) to disperse the semiconfluent 
monolayer of cells, and used between passage numbers 
2 and 3. 
Treatments  of KC cultures 
Semiconfluent KC cultures were always used for 
treatment with histamine (and its derivatives) or 
7°F-a, and the treatment was continued for 48 hr. 
Ftecombinant human TNF-a was obtained from Genen- 
tech Inc., South San Francisco (specific activ- 
ity = 1.7 x lo7 U/mg); histamine, L-histidine, l-meth- 
y lhistidine, and 3-methylhistidine were purchased 
firom Sigma Chemical Corp., St. Louis, MO. The concen- 
tration of histamine or TNF-a is stated in the appropri- 
ate table or figure. Bioactivity and detection of TNF-a 
in conditioned medium which can detect as little as 10 
pg/ml were measured by cytolysis of WEHI cells (cour- 
tesy of Dr. D. Remick; University of Michigan) as  previ- 
ously described (Eskandari e t  al., 1990). All-trans-UCA 
was purchased from Sigma. Cis-UCA was prepared by 
ultraviolet-B (UV-B) irradiation of the trans-isomer. 
Briefly, 3 ml of a 5 mg/ml stock solution of all-trans- 
UCA was placed into a 60 cm Petri dish and UV-B 
irradiated using a bank of four Westinghouse FS-40 
fluorescent lamps a t  a distance of 1 cm above the dish. 
The intensity of the UV-B a t  the level of the liquid was 
measured using a radiometer (International Light Inc., 
Newburgport, MA). Under these conditions, the light 
source delivered over a 30-min irradiation interval a 
total UV-B dose of 300 mJ/cm2. While there was no 
detectable cis-UCA initially as determined using paper 
chromatography (Baden et al., 19661, after irradiation 
there were approximately equal amounts of cis-UCA 
and trans-UCA, as previously described (Ross et al., 
1986). The irradiated solution was stored at 4"C, and 
periodically checked by paper chromatography to verify 
the presence of cis-UCA. For each result, the concentra- 
tion of cis-UCA was determined by dividing the initial 
all-trans-UCA concentration in half. 
Cell immunostaining 
To analyze constitutive expression and induction of 
ICAM-1 (anti-ICAM-1 monoclonal antibody [mAbl 
RRli1; gift of Dr. T. Springer, Boston, MA) and class I1 
major histocompatibility complex (MHC) (anti-HLA-DR 
mAb; L243; Becton-Dickinson, Mountain View, CA) on 
cultured cells by the various treatments, cells were de- 
tached from plastic dishes using 0.03% trypsin/O.Ol% 
EDTA, with indirect immunofluorescence staining, fol- 
lowed by fluorescence-activated cell sorter (FACS) 
analysis as previously described (Griffiths et al., 1989). 
Antibody against the 55-60 kDa form of the TNF-a 
receptor was obtained from Genzyme Corp., Boston, 
MA. Isotype control (Leu 2a, IgG; Becton-Dickinson) 
immunoreactivity was also measured. In addition to 
FACS analysis of single cell suspension, KCs were 
grown in 8-well tissue culture chamber slides (Lab-Tek, 
Nunc Inc., Naperville, IL). After various treatments, 
cell monolayers were fixed with cold acetone for 10 min, 
air dried at room temperature, and then stained for 
ICAM-1 using a sensitive avidin-biotin-peroxidase 
technique (Vectastain Kit, Vector Laboratories, Burl- 
ingame, CA) as described previously (Griffiths and 
Nickoloff, 1989). 
Northern blot hybridization 
RNA from monolayers of untreated or treated KC 
was extracted with guanidine hydrochloride (5.7 M), 
potassium acetate (100 mM, pH L O ) ,  sonicated on ice 
for 60 sec, ethanol precipitated, and centrifuged at 
15,OOOg for 30 min a t  4°C as  previously described 
(Barker et al., 1990). Ten to 15 pg total cellular RNA 
was separated on 1% agarose gels containing 2.2 M 
formaldehyde and electroblotted on nytran membranes 
(Schleicher and Schuell, Keene, NH). The cDNA probe 
for ICAM-1 was cloned by differential hybridization as  
described elsewhere (Eskandari et al., 19901, and the 
cDNA probe for TNF-a was purchased from American 
Type Culture Center, Rockville, MD. Cyclophilin 
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cDNA probe (obtained from C. Griffiths, University of 
Michigan) was used to measure constitutive gene activ- 
ity because it is known to be minimally altered in cul- 
tured KCs (Barker et al., 1990). Each insert was puri- 
fied by agarose gel electrophoresis and electroelution 
and 32P labeled by the random primer method. Nytran 
membranes were hybridized overnight, washed in 0.3 
M sodium chloride, 0.03 M sodium citrate, and 1% so- 
dium dodecyl sulfate (SDS) at 65°C and subjected to  
autoradiography. The results indicated are representa- 
tive of blots obtained in three separate experiments 
using KCs isolated from different donors. The relative 
density of the signals from each lane of the Northern 
blots was determined by scanning laser densitometry 
as previously described for the quantitation of mRNA 
(Barker e t  al., 1990). 
Ligand binding assay  
l"I-rTNF-a was purchased from New England Nu- 
clear (NEN) Research Products, Wilmington, DE (spe- 
cific activity, 44.9 pCi/pg). In a standard binding assay, 
approximately 2-2.5 x lo5 untreated or histamine 
andlor TNF-a treated KCs in 24-well plates were 
washed twice with KBM at 37°C over a 3-hr time inter- 
val. The cells were washed once with Earle's balanced 
salt solution (EBSS) containing 1% bovine serum albu- 
min (binding assay medium) (radioimmunoassay [RIA] 
grade, Sigma). The cells were chilled on ice bath and 
then incubated with 0.5 ml of binding assay medium 
and varied concentrations of 1251-TNF-a (0.015-0.525 
nM). The cultures were maintained at 4°C for the dura- 
tion of binding assay (usually 4 h r  unless otherwise 
specified). The binding assay was terminated by wash- 
ing the monolayers three times with ice-cold binding 
medium. Solubilization of cells was accomplished using 
1 ml of 0.1 N sodium hydroxide containing 1% SDS and 
counted in a gamma counter. Nonspecific binding was 
determined by adding 200-fold excess of unlabeled 
TNF-a to parallel sample wells and was no greater than 
25% of the total amount bound under any treatment 
conditions. Data points represent the average of dupli- 
cate samples with nonspecific binding subtracted. Each 
figure represents the mean of three separate experi- 
ments. 
The uptake of labeled histamine by untreated or 
TNF-a treated cells was measured by following the 
published procedure (Haddock et al., 1987). Tritium- 
labeled histaine hydrochloride (specific activity = 26.4 
Ciimmol) was purchased from NEN Research Products. 
Cells were incubated at 37°C for 2 h r  with 0.038 p M  
[3H] histamine in KGM medium containing 20% fetal 
bovine serum. Incubation was terminated by chilling 
on ice and washing the monolayer three times with cold 
Dulbecco's phosphate-buffered saline. Solubilization of 
the cells was accomplished using 0.25 N sodium hy- 
droxide followed by liquid scintillation counting. To 
study the effect of histamine receptor antagonists on 
cellular uptake of histamine, cells were exposed to ci- 
metidine and diphenhydramine (Sigma) a t  the indi- 
cated concentration shown in Table 1. A stock solution 
of 0.1 M cimetidine in 50% dimethyl sulfoxide (DMSO) 
or 0.1 M diphenhydramine was prepared in KGM. Each 
was diluted just before use with KGM to give appropri- 
ate concentration. 
TABLE 1. L3H1 histamine uptake by cultured keratinocytes in the 
presence of various agents' 
__ Agents used (pM) 
Cell-associated 
radioactivity (dpm) _ _ ~  
0.038 ['HI histamine 
+ unlabeled histamine 
20,232 ? 1,035 
5 13,752 2 1,573 
50 7,259 ? 1,128 
200 5,911 f 919 
500 4,372 i- 855 
(500 Uiml) 
5 19,291 2 1,122 
50 17,594 ? 1,214 
200 16,107 ? 1,327 
500 15,879 ? 1,428 
5 16,128 i- 1,275 
11,126 t 987 50 
200 7,552 i- 873 
500 6,102 ? 799 
5 19,355 ? 1,750 
50 18,811 i- 1,383 
200 19,943 ? 1,412 
500 18,837 -C 1,329 
5 18,569 ? 1,437 
50 17,918 -t 1,328 
200 20,203 t 1,265 
500 18,365 ? 1,353 
'KCs (approximately 450,000) were incubated with 0.038 pM ['HI histamine (0.9 x lo6 
dpm) for 2 hr at 37°C and cell associated radioactivity was determined as described in 
the Materials and Methods section. The concentration of various agents used is indi- 
cated. The results represent the mean of three separate experiments. 
+ 24 hr pretreatment with TNF-a 
+ diphenhydramine 





Induction of KC ICAM-1 detected 
by immunostaining 
The potential ability of histamine to induce KC 
ICAM-1 was screened by performing immunostaining 
of intact semiconfluent monolayers. In the absence of 
any addition to the KGM medium, only a rare isolated 
KC (less than 1 of 100 cells) was ICAM-1 positive (Fig. 
la) .  Upon addition of TNF-a (50 U/ml; 48 hr), numerous 
KCs became ICAM-1 positive (Fig. lb). When KC cul- 
tures were exposed to 5 mM histamine, there was also 
an  increase in the number of ICAM-1-positive cells 
(Fig. lc), which was substantially increased when a 
combination of TNF-u plus histamine was used (Fig. 
Id). These positive direct KC responses to histamine led 
us to explore the potential ability of other histamine 
derivations to induce ICAM-1, either alone, or in combi- 
nation with a low concentration of TNF-a. There was no 
induction of KC ICAM-1 by L-histidine, l-methylhisti- 
dine, 3-methylhistidine, or all-trans-UCA when used as 
a single agents (data not shown). 
In the presence of TNF-a, these same three com- 
pounds failed to either inhibit or increase in an additive 
or synergistic manner KC ICAM-1 expression. How- 
ever, when a UV-B irradiated 5 mM solution of all- 
trans-UCA was used (which contained approximately a 
Fig. 1. Intact KC monolayers immunostained for ICAM-1 expres- 
sion, KCs were maintained for 48 hr in either KGM alone (A), or 
supplemented with 50 Uiml TNF-cx (B), 5 mM histamine (0, or TNF-a 
plus histamine (D). 
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Fig. 2. FACS profile of KCs expressing ICAM-1, but not HLA-DR 
after 48 hr exposure with either KGM alone (untreated), TNF-a (500 
Uiml), histamine (5 mM), or histamine plus TNF-a. 
50% mixture of cis-UCA), KC ICAM-1 was induced in a 
similar manner as histamine (data not shown). TO 
quantitate more precisely these aforementioned re- 
sults, single cell suspensions were prepared and cell 
surface expression determined by FACS analysis. 
Induction of KC ICAM-1 by FACS analysis 
Figure 2 reveals a representative FACS analysis for 
KCs treated for 48 h r  with either KGM alone; TNF-a 
(500 U/ml); histamine (0.5 mM); and the combination of 
TNF-a (500 U/ml) plus histamine (0.5 mM). The solid 
profile areas reveal that  there is a synergistic induction 
of KC ICAM-1 by the combination of TNF-a plus hista- 
mine, compared to the results using these molecules 
singly, in agreement with the immunostaining results 
portrayed in Figure 1. This synergistic reaction was 
specific for ICAM-1, as no change in KC HLA-DR ex- 
pression was noted compared to the isotype control (por- 
trayed by the open profile areas in the upper panels of 
Fig. 2). Figure 3 summarizes a representative experi- 
ment in which the effects of various concentrations of 
both TNF-a and histamine were used. Below 0.1 mM 
histamine had no significant effect, but by 0.5 mM, a 
consistent increase in ICAM-1 expression was detected. 
As shown in the Figure 3C combining TNF-a (500 
U/ml) with increasing concentrations of histamine re- 
sulted in a marked synergistic induction of KC 

















.0001.0005 .001 .005 .01 .05 .5 1 5 10 
Histamine (mM) 
Fig. 3. Summary of mean channel fluorescence values for KCs 
treated with a range of concentrations of either TNF-a alone (A), 
histamine alone (B), or TNF-a(500 U/ml) plus various concentrations 
of histamine (0. 
influence on KC ICAM-1 (with or without TNF-a) for 
the same four compounds described above by immuno- 
staining (L-histidine, l-methylhistidine, 3-methylhis- 
tidine, all-trans-UCA; data not shown). The ability of 
the cis-UCA preparation to induce ICAM-1 is shown in 
Figure 4. On the left side of Figure 4 is the concentra- 
tion dependent induction of KC ICAM-1 by TNF-a 
(with untreated KC ICAM-1 expression in the open 
area). On the right side, KC ICAM-1 expression in- 
duced by either histamine (5 mM) or cis-UCA is pre- 
sented, both without or with TNF-a (500 U/ml). The 
combination of histamine or cis-UCA with TNF-a (500 
U/ml) produced approximately the same FACS profile 
as did the TNF-a (1,000 U/ml) for ICAM-1 expression. 
The mean channel fluorescence intensity values are as 
follows: No TNF-a = 3; TNF-a (50 U/ml) = 9; TNF-a 
(100 U/ml) = 16; TNF-a (500 U/ml) = 26; TNF-a (1,000 
U/ml) = 33; histamine alone (5 mM) = 8; cis-UCA 
alone (2.4 mM) = 7; histamine plus TNF-a (500 
U/ml) = 38; cis-UCA plus TNF-a (500 Uiml) = 35. It 
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Fig. 4. FACS profile of KC ICAM-1 expression induced by various 
concentrations of TNF-u compared to histamine alone, cis-UCA alone, 
and combinations of histamine plus TNF-a,  and cis-UCA plus TNF-a.  
should be noted that these levels of ICAM-1 expression 
using TNF-a are relatively low compared to the ability 
cf interferon gamma (IFN-y) alone (20 U/ml) to induce 
ICAM-1 (value = 164) in agreement with a previous 
report (Norris et al., 1990). 
Induction of KC ICAM-1 mRNA b y  Northern 
blot hybridization 
To determine whether the synergistic interaction be- 
tween histamine and TNF-a with respect to KC 
ICAM-1 expression was related to transcriptional 
events, Northern blot hybridization studies were per- 
formed. As previously observed, KCs produce ICAM-1 
mRNA transcripts after 6 h r  of stimulation with cyto- 
k.ines such as IFN--y and TNF-a (Fig. 5a). In untreated 
EiC cultures, no significant ICAM-1 mRNA was detect- 
able, and the IFN--y (500 U/ml) induction of ICAM-1 
nnRNA served as a positive control. Using histamine 
alone at 0.05 mM and 0.10 mM, no significant ICAM-1 
rnRNA was detectable in agreement with the cell sur- 
face detection by FACS analysis a t  the protein level 
(Fig. 3). Combining TNF-a (500 U/ml) with histamine 
(0.05 or 0.1 mM) produced increased ICAM-1 mRNA 
compared to TNF-a alone. This augmentation in 
ICAM-1 mRNA was synergistic at the mRNA level (as 
determined by laser densitometry analysis of the 
Northern blot, Fig. 5b) which is in agreement with the 
protein expressed at the cell surface as detected by 
FACS analysis. Cyclophilin mRNA results confirm 
equivalent loading of samples per well. 
Figure 6 reveals that combining cis-UCA (1 mM) 
with TNF-a (500 Ulml) also increased ICAM-1 mRNA 
above that induced by either molecule used signly. To 
determine whether the induction of KC ICAM-1 by his- 
tamine was related to increased TNF-a production by 
KCs, two experimental approaches were utilized. First, 
conditioned medium for KC supernatants was collected 
after 6 and 24 h r  of addition of histamine (5 mM) to 
KGM. However, no TNF-a bioactivity was detected us- 
ing a highly sensitive bioassay in the conditioned me- 
dia before or after addition of histamine (data not 
shown). In the second approach, TNF-a mRNA tran- 
scripts were examined by northern blot hybridization. 
Figure 7 reveals that at 6 and 18 h r  after addition of 
histamine (5 mM), no TNF-a transcripts were identi- 
fied. As previously observed (Barker et al., 1990), 
TNF-a autoinduces the detection of TNF-a mRNA 
transcripts in  cultured KCs, and in some experiments 
the combination of histamine plus TNF-a further in- 
creased the detection of TNF-a mRNA transcripts. 
Whether this increased amount of TNF-a mRNA tran- 
scripts was accompanied by a concomitant increase in 
translated and secreted protein could not be deter- 
mined because of the cross-reactivity in the bioassay 
between the added exogenous recombinant TNF-a and 
the naturally produced TNF-a. 
Measurement of TNF-a surface receptors b y  
ligand binding and FACS analysis 
To determine whether the marked increase in 
ICAM-1 induction was due to the alteration of TNF-a 
receptor number or affinity in the presence of hista- 
mine, surface binding of labeled TNF-a was next car- 
ried out. Figure 8 shows a time course of TNF-a binding 
to confluent cultures of KCs a t  4°C. Results show that 
specific binding (total binding minus nonspecific bind- 
ing which was determined by including 200-fold excess 
nonlabeled TNF-a) reached a plateau between S 1 2  hr  
in agreement with a previous report (Pillai et al., 1989). 
At 37"C, the maximal binding was achieved by 3 hr  
(data not shown). However, at 37"C, a considerable cell 
associated radioactivity was internalized (Pillai et al., 
1989). Also the extent of degradation of labeled TNF-a 
was minimal a t  4°C (Pillai et al., 1989). Hence, all the 
binding assays with '"I-TNF-a were carried out a t  4°C 
for 6 6  hr. KCs in culture treated with 5.0 mM hista- 
mine for 48 hr, or untreated cultures were washed and 
used for 1251-TNF-a binding studies. The specific bind- 
ing to KCs increased with increasing concentrations of 
labeled TNF-a and achieved saturation with and with- 
out histamine between 0.4 and 0.55 nM (Fig. 9a). Using 
histamine at 5.0 nM concentration which did not in- 
hibit KC proliferation or alteration in morphology, no 
difference in lZ5I-TNF-a binding was observed (Fig. 9a). 
Scatchard plot analysis of the ligand binding data 
yielded linear plots (regression coefficient = 0.9) indi- 
cating the presence of a single class of high affinity 
binding sites (Fig. 9b). The dissociation constant for 
histamine treatment or non-treated cell was calculated 
to be 0.25 t 0.03 nM with 1,600 k 150 receptor sites 
per KC. Neither the number of receptors per cell nor 
the affinity constant for TNF-a was altered by includ- 
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Fig. 5. a: Northern blot for KC ICAM-1 and cyclophilin (Cy) mRNA levels 6 hr after stimulation with 
either KGM alone (lane 1); 500 Uiml IFN-y (lane 2); .05 mM histamine (lane 3); 0.1 mM histamine (lane 
4); 500 Uiml TNF-u (lane 5); .05 mM histamine plus TNF-a (lane 6); or 0.1 mM histamine plus TNF-u 
(lane 7). b Relative density of the signals for each of the lanes of the Northern blot for ICAM-1 as 
determined by scanning laser densitometry. 
ing 0.1 mM histamine in binding assay medium or by 
exposing KCs to a much higher concentration of hista- 
mine such as 2 mM. By FACS analysis, KC cell surface 
immunostaining for the 55-60 kDa TNF-a receptor re- 
vealed a single peak with a mean channel fluorescence 
value of 18 (isotype control value = 4). Pretreating the 
KCs for 24 hr with either histamine (5 mM) or cis-UCA 
(2.5 mM) did not significantly change the FACS profile 
(data not shown). 
Characterization of 3H-histamine binding to KCs 
While histamine did not modulate the affinity or 
number of TNF-or receptors, we asked the reciprocal 
question; does TNF-a modulate histamine binding? Be- 
cause no Drevious studies have been Dublished detail- 
ing the adility of histamine to bind akd stimulate KCs, 
ing 3H-histamine. Uptake of histamine in KCs was ob- 
served when the binding studies were carried out at 
we explored appropriate ligand binding parameters us- Fig. 6. Northern blot of KC ICAM-1 and cyclophilin mRNA levels 6 hr after stimulation with either KGM alone (lane 1); 500 U/ml IFN-y 
(lane 2); 500 uimi T N F - ~  (lane 3); I mM cis-UCA (lane 4); or cis-UCA 
plus TNF-a (lane 5). 
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Fig. 7. Northern blot of KC TNF-a and cyclophilin mRNA levels 6 
and 18 hr after stimulation with either KGM alone (6 hr-lane 1; 18 
hr-lane 5); 500 U/ml TNF-a alone (6 hr-lane 2; 18 hr-lane 6); 5 mM 
histamine alone (6 hr-lane 3; 18 hr-lane 7);  or histamine plus TNF-a 
(6 hr-lane 4; 18 hr-lane 8). 
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Time course for '"1-TNF-a bind to KCs at 4°C Fig. 8. 
37°C and in the presence of high concentrations of se- 
rum (20%), as the binding of [3H] histamine was ex- 
tremely low at 4°C and lower concentrations of serum 
resulted in a significant nonspecific binding (data not 
shown). The presence of 20% fetal calf serum in the 
KGM incubation is sufficient to reduce the nonspecific 
binding to a level of 3040%. A high level of nonspecific 
binding has been reported (Haddock et al., 1987) when 
["HI histamine uptake was studied with human vascu- 
lar endothelial cells. 
KCs were incubated with 0.03 pM r3H1 histamine in 
the presence of different concentrations of unlabeled 
histamine and cell associated radioactivity was deter- 
mined. The results of competition analysis demonstrate 
the specificity of binding between unlabeled and la- 
beled histamine (Table 1). At 200 IJ.M of unlabeled his- 
tamine, the binding was reduced by 70%. Table 1 com- 
pares the influence of TNF-a, diphenhydramine (H, 
antagonist), and cimetidine (H, antagonist) on L3H1 his- 
tamine uptake. With TNF-a pretreated KCs (500 U/ml 
for 24 hr), or  inclusion of TNF-a in the binding medium, 
no difference in [3H] histamine uptake was observed in 
comparison with untreated cultures. It thus appears 
that the TNF-a does not modulate the affinity or num- 
ber of histamine receptors. Inhibition of uptake of la- 
beled histamine by cimetidine in KCs indicates that the 
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Fig. 9. a: Concentration dependent binding of '"1-TNF-a to KCs 
maintained either in KGM (closed circles) or treated for 48 hr with 
histamine (5 mM; open circles). b: Scatchard analysis of ligand bind- 
ing data reveals a single class of high affinity TNF-a receptors which 
is not significantly influenced by exposure to histamine. 
volved. In contrast, the inability of the antagonist 
diphenhydramine to inhibit labeled histamine uptake 
by KCs suggests that H, receptors do not play a signifi- 
cant role in the observed uptake. Failure to inhibit the 
uptake of t3H1 histamine by all-trans-UCA or its cis 
isomer even at  higher concentration indicates that 
UCA uptake in KCs is not mediated through the hista- 
mine receptor. 
DISCUSSION 
The earliest inflammatory and immunological re- 
sponses in skin can be viewed as the result of a cascade 
of molecular mediators produced by several different 
resident cell types. In this study, we focused on three 
such mediators produced by KCs and/or mast cells; i.e., 
TNF-a, UCA, and histamine. TNF-a is being recog- 
nized as a key cytokine in several common cutaneous 
disorders such as allergic and irritant contact dermati- 
tis, and in UV-B induced tolerance to epicutaneous hap- 
tens (Barker et al., 1991; Griffiths et al., 1991; Piquet et 
al., 1991; Vermeer and Streilein, 1990). While a previ- 
ous study suggested that mast cell derived proinflam- 
matory mediators together with TNF-a were important 
in the development of a cellular inflammatory response 
(via induction of endothelial cell adhesion molecules), it 
was not clear whether histamine and TNF-a could syn- 
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ergize in such reactions (Klein et al., 1989). Moreover, 
while the rapidly evolving dissection of the immuno- 
modulatory properties of UV-B have increasingly cen- 
tered on TNF-a, and the isomerization of all-trans- 
UCA to cis-UCA (reviewed in Noonan and DeFabo, 
1992), no previous study specifically addressed whether 
cis-UCA plus TNF-cr could augment KC ICAM-1 ex- 
pression. 
The current data indicate that both histamine and 
cis-UCA can directly induce KC ICAM-1 expression, 
albeit rather weakly in comparison with either TNF-a 
or IFN-7. However, both histamine and cis-UCA, when 
combined with TNF-a, significantly augment KC 
ICAM-1 expression (at the mRNA and protein level), 
without influencing class I1 MHC (i.e., HLA-DR) ex- 
pression. Other histamine related compounds such as 
L-histidine, 1-methylhistidine, 3-methylhistidine, and 
all-trans-UCA lacked any capacity, when used either 
singly or in combination with TNF-a, to influence KC 
ICAM-1 expression. The interaction between hista- 
mine and cis-UCA with TNF-a did not involve detect- 
able changes in either the number or affinity of either 
the TNF-a receptor or the histamine receptor. TNF-a 
receptor expression was characterized by both ligand 
binding with Scatchard analysis, as well as by flow 
cytometry. The affinity constant and number of recep- 
tors determined in our laboratory (0.25 nM; 1,600 sites 
per cell) are in good agreement with a previous group of 
investigators (0.28 nM; 1,250 sites per cell; Pillai et al., 
19891, as was our cell surface immunodetection for the 
epithelial type (i.e., 55-60 kDa) of the TNF-a receptor 
(Hohmann et al., 1989; Trefzer et al., 1991). The ability 
of histamine to induce ICAM-1 expression was not ac- 
companied by any detectable increase in KC production 
of TNF-a as measured at the mRNA or functional pro- 
tein level in the conditioned medium. However, it is 
possible that both histamine and cis-UCA can induce a 
small increase in TNF-a which immediately bound to 
unoccupied high affinity cell surface receptors. Experi- 
ments utilizing polymerase chain reaction technology 
to detect relatively small changes in transcriptional 
events may be useful in this regard. It should be noted 
that a previous group investigating the action of IFN-)I 
plus TNF-a also could not correlate the synergistic re- 
sponse of the KCs to IFN-? with any detectable change 
in TNF-a receptor expression (Trefzer et al., 1991). 
With respect to the KC cell surface receptors for his- 
tamine, it appears that KCs possess a type 2 receptor 
because 3H-histamine binding was inhibited by cimeti- 
dine (an H2 receptor antagonist) but not by diphenhy- 
dramine (an HI receptor antagonist). The functional 
response of some cell types bearing H2 receptors in- 
volves activation of phospholipase C (reviewed in Mit- 
suhashi and Payan, 1992) and we have previously ob- 
served that ICAM-1 but not HLA-DR can be induced by 
phorbol ester which is a protein kinase C activator 
(Griffiths et al., 1990). Thus, histamine may augment 
TNF-(r mediated IC AM-1 expression by postreceptor 
binding events such as second messenger systems in- 
volving phospholipase Uprotein kinase C. Moreover it 
appears that with monocytes, histamine can suppress 
TNF-ol production via H, receptors, and this may serve 
as a negative feedback loop to prevent excessive TNF-ol 
production by both recruited blood derived monocytes, 
as well as KCs within a skin site undergoing an inflam- 
matory or immunological reaction (Vannier et al., 
1991). Because neither cis-UCA nor trans-UCA influ- 
enced %-histamine binding, it appears that the photo- 
receptor for UV-B light on KCs (i.e., cis-UCA receptor) 
is not the histamine receptor. A previous study reported 
that the immunosuppressive effects of UV-B, as mea- 
sured by reduction in epidermal Langerhans cell num- 
bers, was blocked by a type 1 histamine receptor antag- 
onist such as terfenadine, as well as by a type 2 receptor 
antagonist such as cimetidine (Norval et al., 1990). 
Thus, Langerhans cells may possess a histamine-like 
photoreceptor for UCA different from the KC photore- 
ceptor, which is not influenced by histamine receptor 
antagonists. 
Our data indicate that during the evolution of a cuta- 
neous inflammatory reaction, important cross-talk 
may occur between epidermal KCs and dermal mast 
cells involving soluble mediators such as TNF-cr, hista- 
mine, and cis-UCA. Based on our earlier hypothesis for 
cutaneous reactions (Barker et al., 1990), the early ini- 
tiation phase can now be viewed as resulting from 
TNF-a plus the enhancing effects of histamine and cis- 
UCA for the up-regulation of KC ICAM-1. However, as 
pointed out in the original hypothesis, the subsequent 
amplification phase, which features the involvement of 
T-cell derived IFN--y , represents a substantially more 
potent cytokine for the further induction of KC 
ICAM-1. With respect to two common T-cell mediated 
diseases exacerbated by bacterial infections such as 
psoriasis and atopic dermatitis that feature mast ceIIs 
and cytokine activated KCs, we have recently observed 
that KCs can present bacterial derived superantigens 
to resting T cells (Nickoloff et al., 1992). This autolo- 
gous T-cell response was inhibited by antibodies di- 
rected against the CD-lla/CD-18 antigens on T cells 
and ICAM-1 on KCs. Thus, the ability of histamine and 
cis-UCA to augment TNF-a inducible KC ICAM-1 ex- 
pression may convey critically important immunomod- 
ulatory signals to both KCs and T cells recruited from 
the circulation during inflammatory reactions of the 
skin. AdditionaI additive, synergistic, and antagonistic 
functional interactions among these three key media- 
tors of inflammatory and immune reactions need to be 
investigated in other cutaneous cell types beyond KCs, 
and in a range of skin diseases, to more fully assess the 
potential therapeutic impact of these current in vitro 
results. 
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